Key drivers behind GLP-1 and addiction research include: Rapid expansion in the use of GLP-1 medications such as semaglutide (Ozempic and Wegovy) and tirzepatide (Maunjaro and Zepbound) Reports of changes in cravings, alcohol use, or reward-seeking behaviors beyond weight loss Increased public conversation and clinical curiosity about psychological and behavioral effects Scientific interest in GLP-1 activity within reward pathways and dopamine signaling Recognition that appetite regulation and addiction involve shared neural mechanisms This research is still emerging, and findings should be interpreted with caution
People who do not keep a healthy lifestyle and a healthy diet will simply regain the weight back, and then claim the medication did not work
However, results vary from individual to individual
Clinical studies show adequate choline intake lowers liver enzyme levels and improves hepatic insulin sensitivity, both markers of improved liver function and metabolic health
Phone (760) SOM-SKIN (760) 766-7546 Visit Us 25 E E St Encinitas, CA 92024 Parking Free parking behind the building at E St & Vulcan Ave, or a paid parking garage entrance on F St & 101.
The real challenge, however, is maintaining these results over time
